We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| International Biotechnology Trust Plc | LSE:IBT | London | Ordinary Share | GB0004559349 | ORD 25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.00 | 1.65% | 616.00 | 608.00 | 616.00 | 612.00 | 612.00 | 612.00 | 19,950 | 16:35:17 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Trust,ex Ed,religious,charty | 12.06M | 6.81M | 0.1733 | 35.31 | 240.63M |
From Apr 2019 to Apr 2024
TIDMIBT
RNS Number : 0339Y
Intl. Biotechnology Trust PLC
16 August 2018
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)
Portfolio Update as at 31 July 2018
Hot Features
Premium
Net Assets GBP251m
Net Assets per share 670p
Share price 668p
Total value of unquoted GBP28m
investments
Total number of portfolio
companies 74
Dividend 4% of NAV per
annum
Top Ten Quoted Investments
Company Name % NAV
Celgene 6.9
Illumina 5.1
Vertex 4.4
Genmab 3.9
Exelixis 3.7
Regeneron 3.5
Morphosys 3.4
Alexion 3.3
Neurocrine 3.3
Array 3.2
-----------
Total 40.7
Geographical Allocation % NAV
US & Canada 86
Europe 14
-----------
Total 100
Quoted/Unquoted Allocation % NAV
Quoted 89
Unquoted 11
-----------
Total 100
NAV % Market Cap % NAV
Large Cap >USD10BN 35
Mid Cap =USD1-10BN 41
Small Cap <USD1BN 24
-----------
Total 100
NAV % by Therapeutic Areas % NAV
Oncology 47
CNS 13
Rare diseases 14
Ophthalmology 7
Infectious Diseases 3
Inflammation 2
Metabolic 2
Medtech 2
Other 10
-----------
Total 100
BNP Paribas Secretarial Services Limited
Company Secretary
16 AUGUST 2018
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
PFUBGGDIBGBBGIL
(END) Dow Jones Newswires
August 16, 2018 06:03 ET (10:03 GMT)
1 Year International Biotechnol... Chart |
1 Month International Biotechnol... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
